RETA - Reata Pharmaceuticals Inc - Class A
IEX Last Trade
167.16
0.740 0.443%
Share volume: 1,001,401
Last Updated: Tue 08 Aug 2023 09:59:56 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$166.42
0.74
0.45%
Summary score
24%
Profitability
0%
Dept financing
25%
Liquidity
75%
Performance
35%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2019 - 30-Jun-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-106.57%
Return on assets
-12.17%
Return on sales
-8133.27%
Return on invested capital
-41.1%
Total debt ratio
80.46%
Debt ratio change over timeo
-0.75%
Current Ratio
7.61%
Quick Ratio
7.61%
Cash Position Ratio
7.38%
Short-term ratios 30-Jun-2022 - 30-Jun-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-327.32%
Return on assets
-17.01%
Return on sales
-23351.25%
Return on invested capital
-301.3%
Total debt ratio
105.86%
Debt ratio change over timeo
-1.68%
Current Ratio
6.21%
Quick Ratio
6.2%
Cash Position Ratio
5.92%
Last quarter ratios 30-Jun-2023
The data are presented for the financials results of the last quarter.
Return on equity
221.1%
Return on assets
-16.16%
Return on sales
-357%
Return on invested capital
-792.47%
Total debt ratio
82.63%
Debt ratio change over time
-1.1%
Current Ratio
3.21%
Quick Ratio
3.19%
Cash Position Ratio
2.64%
Performance ratios (change over 4 years) 30-Jun-2019 - 30-Jun-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-1.49%
Return on assets
-107.49%
Return on sales
1139.39%
Return on invested capital
26.69%
Total debt ratio
-75.02%
Debt ratio change over time
-0.75%
Current Ratio
1.39%
Quick Ratio
1.39%
Cash Position Ratio
1.27%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RETA | VLON | ELAT | CEREW |
|---|---|---|---|---|
| Return on equity | -106.57% | 0% | 0% | 0% |
| Return on assets | -12.17% | 0% | 0% | 0% |
| Return on sales | -8133.27% | 0% | 0% | 0% |
| Return on invested capital | -41.1% | 0% | 0% | 0% |
| Profitability | 0% | 0% | 100% | 0% |
| Total debt ratio | 80.46% | 0% | 0% | 0% |
| Debt ratio change over time | -0.75% | 0% | 0% | 0% |
| Dept financing | 25% | 0% | 25% | 0% |
| Current Ratio | 6.21% | 0% | 0% | 0% |
| Quick Ratio | 6.2% | 0% | 0% | 0% |
| Cash Position Ratio | 5.92% | 0% | 0% | 0% |
| Liquididy | 75% | 0% | 0% | 0% |
| Short-term ratios | RETA | VLON | ELAT | CEREW |
|---|---|---|---|---|
| Return on equity | -327.32% | 0% | 0% | 0% |
| Return on assets | -17.01% | 0% | 0% | 0% |
| Return on sales | -23351.25% | 0% | 0% | 0% |
| Return on invested capital | -301.3% | 0% | 0% | 0% |
| Profitability | 0% | 0% | 100% | 0% |
| Total debt ratio | 105.86% | 0% | 0% | 0% |
| Debt ratio change over time | -1.68% | 0% | 0% | 0% |
| Dept financing | 25% | 0% | 25% | 0% |
| Current Ratio | 6.21% | 0% | 0% | 0% |
| Quick Ratio | 6.2% | 0% | 0% | 0% |
| Cash Position Ratio | 5.92% | 0% | 0% | 0% |
| Liquididy | 75% | 0% | 0% | 0% |